Literature DB >> 28422240

Zwitterionic pyrrolidene-phosphonates: inhibitors of the glycoside hydrolase-like phosphorylase Streptomyces coelicolor GlgEI-V279S.

Sri Kumar Veleti1, Cecile Petit, Donald R Ronning, Steven J Sucheck.   

Abstract

We synthesized and evaluated new zwitterionic inhibitors against glycoside hydrolase-like phosphorylase Streptomyces coelicolor (Sco) GlgEI-V279S which plays a role in α-glucan biosynthesis. Sco GlgEI-V279S serves as a model enzyme for validated anti-tuberculosis (TB) target Mycobacterium tuberculosis (Mtb) GlgE. Pyrrolidine inhibitors 5 and 6 were designed based on transition state considerations and incorporate a phosphonate on the pyrrolidine moiety to expand the interaction network between the inhibitor and the enzyme active site. Compounds 5 and 6 inhibited Sco GlgEI-V279S with Ki = 45 ± 4 μM and 95 ± 16 μM, respectively, and crystal structures of Sco GlgE-V279S-5 and Sco GlgE-V279S-6 were obtained at a 3.2 Å and 2.5 Å resolution, respectively.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28422240      PMCID: PMC6169318          DOI: 10.1039/c7ob00388a

Source DB:  PubMed          Journal:  Org Biomol Chem        ISSN: 1477-0520            Impact factor:   3.876


  35 in total

Review 1.  Protein engineering of bacterial alpha-amylases.

Authors:  J E Nielsen; T V Borchert
Journal:  Biochim Biophys Acta       Date:  2000-12-29

Review 2.  Glycosidase mechanisms.

Authors:  Andrea Vasella; Gideon J Davies; Matthias Böhm
Journal:  Curr Opin Chem Biol       Date:  2002-10       Impact factor: 8.822

3.  Combinatorial approach toward synthesis of small molecule libraries as bacterial transglycosylase inhibitors.

Authors:  Hao-Wei Shih; Kuo-Ting Chen; Shao-Kang Chen; Chia-Ying Huang; Ting-Jen R Cheng; Che Ma; Chi-Huey Wong; Wei-Chieh Cheng
Journal:  Org Biomol Chem       Date:  2010-03-29       Impact factor: 3.876

4.  Structure and synthesis of nojirimycin.

Authors:  S Inouye; T Tsuruoka; T Ito; T Niida
Journal:  Tetrahedron       Date:  1968-03       Impact factor: 2.457

5.  Nojirimycin, a new antibiotic. II. Isolation, characterization and biological activity.

Authors:  N Ishida; K Kumagai; T Niida; T Tsuruoka; H Yumoto
Journal:  J Antibiot (Tokyo)       Date:  1967-03       Impact factor: 2.649

6.  The role of Asp-295 in the catalytic mechanism of Leuconostoc mesenteroides sucrose phosphorylase probed with site-directed mutagenesis.

Authors:  Mario Mueller; Bernd Nidetzky
Journal:  FEBS Lett       Date:  2007-03-05       Impact factor: 4.124

7.  Self-poisoning of Mycobacterium tuberculosis by targeting GlgE in an alpha-glucan pathway.

Authors:  Rainer Kalscheuer; Karl Syson; Usha Veeraraghavan; Brian Weinrick; Karolin E Biermann; Zhen Liu; James C Sacchettini; Gurdyal Besra; Stephen Bornemann; William R Jacobs
Journal:  Nat Chem Biol       Date:  2010-03-21       Impact factor: 15.040

Review 8.  Unexpected and widespread connections between bacterial glycogen and trehalose metabolism.

Authors:  Govind Chandra; Keith F Chater; Stephen Bornemann
Journal:  Microbiology       Date:  2011-04-07       Impact factor: 2.777

9.  Alpha-rhamnosidase inhibitory activities of polyhydroxylated pyrrolidine.

Authors:  Jin Hyo Kim; Marcus J Curtis-Long; Woo Duck Seo; Jin Hwan Lee; Byong Won Lee; Yong Jin Yoon; Kyu Young Kang; Ki Hun Park
Journal:  Bioorg Med Chem Lett       Date:  2005-10-01       Impact factor: 2.823

Review 10.  Mechanistic analogies amongst carbohydrate modifying enzymes.

Authors:  Luke L Lairson; Stephen G Withers
Journal:  Chem Commun (Camb)       Date:  2004-09-27       Impact factor: 6.222

View more
  2 in total

1.  Stereoselective synthesis of a 4-⍺-glucoside of valienamine and its X-ray structure in complex with Streptomyces coelicolor GlgE1-V279S.

Authors:  Anshupriya Si; Thilina D Jayasinghe; Radhika Thanvi; Donald R Ronning; Steven J Sucheck
Journal:  Sci Rep       Date:  2021-06-28       Impact factor: 4.379

Review 2.  Promising Recent Strategies with Potential Clinical Translational Value to Combat Antibacterial Resistant Surge.

Authors:  Partha Karmakar; Vishwanath Gaitonde
Journal:  Medicines (Basel)       Date:  2019-01-31
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.